Virbac
Virbac SA is a French multinational animal health pharmaceutical enterprise dedicated exclusively to veterinary medicine. The company researches, formulates, manufactures, and markets vaccines, parasiticides, dermatological treatments, antibiotics, and nutritional products for companion animals and livestock. Main revenue drivers consist of global commercial sales of veterinary pharmaceuticals, vaccines, and animal healthcare products to veterinary clinics and farm distributors. Virbac serves veterinarians, pet owners, livestock farmers, and aquaculture operators across Europe, North America, Latin America, and Asia-Pacific. The company holds a market-leading global position as one of the largest dedicated animal health pharmaceutical corporations in the world. Headquartered in Carros, France, Virbac SA is listed on Euronext Paris.
2 of the funds FundTelligence covers report a position in Virbac.
- Legal name
- Virbac SA
- Sector
- Health Care
- Country
- France
- Funds holding it
- 2
- Exposure themes
- Agricultural Technology & Inputs, Food & Agriculture Transformation, Inputs & Biologicals
Funds holding Virbac
- T. Rowe Price European Smaller Companies Equity — T. Rowe Price · 1.67 % (full portfolio disclosed, September 2026)
- Handelsbanken Global SMB Index Criteria — Handelsbanken · 0.02 % (full portfolio disclosed, October 2026)